Inventor profile of:

Fernand LABRIE

City:

Quebec

Country:

Canada

Published Applications:

23

Last publication date:

2023-11-02

Top Assignees for applications by Fernand LABRIE

The entities that hold a legal rights for patent applications filed by inventor LABRIE Fernand:

Recent patent applications by LABRIE Fernand

Fernand LABRIE from Quebec, CA has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2023-11-02
US20230346800A1
Human necessities

REDUCTION OF THE INCIDENCE OR RECURRENCE OF BREAST CANCER IN POSTMENOPAUSAL WOMEN TREATED WITH INTRAVAGINAL SEX STEROID PRECURSOR

#2 | 2022-10-06
US20220313703A1
Human necessities

Reduction of the incidence or recurrence of breast cancer in postmenopausal women treated with intravaginal sex steroid precursor

#3 | 2021-03-11
US20210069169A1
Human necessities

PHARMACEUTICAL COMPOSITIONS

#4 | 2019-09-05
US20190269697A1
Human necessities

Method of treating and preventing loss of cognition

#5 | 2018-09-27
US20180271880A1
Human necessities

Sex steroid precursors alone or in combination with selective estrogen receptor modulators for the prevention and treatment of sexual dysfunction in postmenopausal women

#6 | 2017-10-12
US20170290847A1
Human necessities

Treatment of male androgen deficiency symptoms or diseases with sex steroid precursor combined with SERM

#7 | 2016-03-03
US20160058774A1
Human necessities

Sex steroid precursors alone or in combination with selective estrogen receptor modulators for the prevention and treatment of dyspareunia in postmenopausal women

#8 | 2015-09-10
US20150250802A1
Human necessities

Treatment of male androgen deficiency symptoms or diseases with sex steroid precursor combined with SERM

#9 | 2015-06-25
US20150175576A1
Chemistry; metallurgy

Non-steroidal antiandrogens and selective androgen receptor modulators with a pyridyl moiety

#10 | 2013-12-17
US10387043
-

Methods of treating and/or suppressing insulin resistance

#11 | 2013-09-19
US20130244989A1
Human necessities

Treatment of Alzheimer's disease, loss of cognition, memory loss and dementia with sex steroid precursors in combination with selective estrogen receptor modulators

#12 | 2012-12-20
US20120322778A1
Human necessities

Pharmaceutical compositions

#13 | 2012-11-08
US20120283230A1
Human necessities

Pharmaceutical compositions

#14 | 2011-12-22
US20110312925A1
Human necessities

Methods of treating or preventing estrogen-related diseases

#15 | 2010-02-04
US20100028879A1
Chemistry; metallurgy

Modulators of HSD17b7 for treating acne or hyperseborrhea

#16 | 2010-02-04
US20100028878A1
Physics

Modulators of UDP-glucose ceramide glucosyltransferase for treating acne or hyperkeratinization

#17 | 2010-01-28
US20100021893A1
Physics

Modulators of lanosterol synthetase for treating acne or hyperseborrhea

#18 | 2010-01-28
US20100021892A1
Physics

Modulators of SC4MOL for treating acne or hyperseborrhea

#19 | 2009-12-03
US20090298074A1
Physics

Modulators of ELOVL5 for treating acne or hyperseborrhea

#20 | 2009-10-15
US20090258356A1
Physics

Modulators of the transporter ABCD3 for treating acne or hyperseborrhea

#21 | 2009-10-01
US20090246776A1
Physics

Modulators of scarb-1 for treating acne or hyperseborrhea

#22 | 2009-02-26
US20090054383A1
Human necessities

Pharmaceutical compositions

#23 | 2006-12-21
US20060287327A1
Chemistry; metallurgy

Helix 12 directed non-steroidal antiandrogens

InventorID:

1204119 ⎘